No costs are anticipated in the current PBM contract. However, changes to subsequent pharmacy benefit manager contracts in response to the proposed legislation may increase costs. Costs may increase as a result of potential alteration of MAC pricing definition within the PBM contract relating to drugs with three or less therapeutically equivalent drugs and generic drugs in an exclusivity period.
No fiscal impact is anticipated if PEHP requires dispensing fees and allowed amounts remain in the same for physicians and pharmacists.
No fiscal impact, because SB 78 does not alter benefit design.
No fiscal impact for PEHP.
No fiscal impact for PEHP. PEHP doesn't currently contract or provide services for Medicaid or CHIP.